Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Krystal Biotech Inc shares valued at $4,274,040 were sold by Krishnan Suma on Mar 11 ’24. At $170.96 per share, Krishnan Suma sold 25,000 shares. The insider’s holdings dropped to 1,550,882 shares worth approximately $247.63 million following the completion of this transaction.
Also, Krishnan Krish S sold 25,000 shares, netting a total of over 4,274,040 in proceeds. Following the sale of shares at $170.96 each, the insider now holds 1,550,882 shares.
Before that, Krishnan Suma had sold 25,000 shares from its account. In a trade valued at $4,273,679, the President, R&D traded Krystal Biotech Inc shares for $170.95 each. Upon closing the transaction, the insider’s holdings decreased to 25,000 shares, worth approximately $257.43 million.
As published in their initiating research note from Goldman on November 20, 2023, Krystal Biotech Inc [KRYS] has been a Buy and the price target has been revised to $160. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in late October. As of October 12, 2023, Citigroup has initiated its “Buy” rating for KRYS. Earlier on September 07, 2023, Berenberg initiated its rating. Their recommendation was “a Buy” for KRYS stock.
Analyzing KRYS Stock Performance
During the last five days, there has been a surge of approximately 0.39%. Over the course of the year, Krystal Biotech Inc shares have jumped approximately 28.70%. Shares of the company reached a 52-week high of $189.97 on 03/05/24 and a 52-week low of $107.50 on 02/22/24. A 50-day SMA is recorded $165.68, while a 200-day SMA reached $128.95. Nevertheless, trading volume fell to 0.41 million shares from 0.2 million shares the previous day.
Support And Resistance Levels for Krystal Biotech Inc (KRYS)
According to the 24-hour chart, there is a support level at 154.50, which, if violated, would cause prices to drop to 149.33. In the upper region, resistance lies at 162.50. The next price resistance is at 165.33. RSI (Relative Strength Index) is 45.17 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.02, which suggests the price will decrease in the coming days. Percent R is at 72.12%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
